News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

Stop Wasting Water! New Study Reveals How to Get People to Conserve – And It’s Not Just About Money
News Release

BALTIMORE, MD, April 30, 2025 – As droughts worsen and water shortages hit communities worldwide, a new study in the INFORMS journal Decision Analysis has uncovered a smarter way to get people to save water – without breaking the bank.

Read More
China’s rare earth minerals power the modern world. Banning their export could destroy it
Media Coverage

Beijing has a virtual monopoly on rare earth minerals—the materials that power everything from military planes to your electric toothbrush.

Read More
Trump’s tech tariff confusion
Media Coverage
The Trump administration’s back-and-forth moves on tariffs for technology products are stirring confusion in a sector heavily reliant on global supply chains.  
Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
How Mathematics Can Help You Vote This November

How Mathematics Can Help You Vote This November

The Hill, September 14, 2020

We are just under two months before Election Day. As voters weigh the choices, mathematics offers a clue in how you should cast your vote in November. Every decision we make is weighed amongst several criteria. When we opt for the fries over the salad, the satisfying taste of greasy potatoes outweighs the health benefits of greens and fiber. Other days, we pick the apple over the apple pie, for the exact opposite reason. These choices are made with limited thought, often more by impulse rather than with sound reason. 

CEOs Bring in Big Bucks, Even More When a CFO is Hired after Them

CEOs Bring in Big Bucks, Even More When a CFO is Hired after Them

CEOWorld Magazaine, September 9, 2020

It’s common knowledge that chief executive officers (CEOs) of companies are highly paid, but new research shows a certain phenomenon can bump that yearly salary up even higher—about 10% higher. New research in the INFORMS journal Management Science finds CEO compensation climbs if they appoint a chief financial officer (CFO) after them. The increased compensation is mostly concentrated in the early years of the newly hired CFO’s tenure and in components of compensation that vary with hitting analyst-based earnings targets. The work suggests that some finance chiefs might be pressured to tweak earnings to boost the stock price, and as a result, CEO compensation.

The Sensible Way to Return to College During the COVID-19 Pandemic

The Sensible Way to Return to College During the COVID-19 Pandemic

The Washington Times, September 9, 2020

A normal return to college this fall is anything but normal. The variety of COVID-19 impacted education plans range from fully online to fully in-person, and everything in between. Many colleges have cancelled or delayed football and other sports this fall. Colleges have welcomed students back to campus, and students are glad to be back; some have reciprocated with new infections, mostly asymptomatic. College life has been upended, with no end in sight.

 Two COVID Vaccines in Phase 3; CDC Plans Distribution

Two COVID Vaccines in Phase 3; CDC Plans Distribution

The Corvallis Advocate, September 8, 2020

Currently, dozens of experimental COVID-19 vaccines are being developed in the United States and throughout the world, including seven vaccine candidates funded by the U.S. government, according to a report by the Statesman Journal. Two of the seven vaccines are in Phase 3 clinical trials, which now begs the question: how will the vaccine be distributed, and who will be first to receive it when it’s available?

Coronavirus Update: Vaccine Makers Promise Safety, Lingering Effects From Severe Cases

Coronavirus Update: Vaccine Makers Promise Safety, Lingering Effects From Severe Cases

Consumer Affairs, September 8, 2020

Nine of the pharmaceutical companies actively working on a coronavirus (COVID-19) vaccine have pledged to make sure whatever drug they come up with is safe for people, even if it means taking longer to develop. In a joint statement, the U.S. and European firms, including AstraZeneca, Pfizer, and GlaxoSmithKline, promised to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first Covid-19 vaccines.”

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine